Ribonuclease L is not critical for innate restriction and adaptive immunity against Friend retrovirus infection

Virology

Volumn 443, Issue 1, 2013, Pages 134-142

  Li, Sam X ^a,b   Barrett, Bradley S ^a   Harper, Michael S ^a,b   Heilman, Karl J ^a   Halemano, Kalani ^a,b   Steele, Amanda K ^a   Guo, Kejun ^a   Silverman, Robert H ^c   Santiago, Mario L ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Apobec3; Friend retrovirus; Humoral immunity; Restriction factor; Ribonuclease L

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3; HYDROLASE; IMMUNOGLOBULIN G; NUCLEOTIDYLTRANSFERASE; OLIGOADENYLATE SYNTHETASE 1; RIBONUCLEASE L; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FRIEND LEUKEMIA VIRUS; GENE DELETION; HOST RESISTANCE; IN VIVO STUDY; INNATE IMMUNITY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RETROVIRUS INFECTION; TRANSCRIPTION INITIATION; VIREMIA; WILD TYPE;

ADAPTIVE IMMUNITY; ANIMALS; DISEASE MODELS, ANIMAL; ENDORIBONUCLEASES; FRIEND MURINE LEUKEMIA VIRUS; IMMUNITY, INNATE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RETROVIRIDAE INFECTIONS;

MUS;

EID: 84879783102     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.05.009     Document Type: Article

References (52)

1. Ammann C.G., Messer R.J., Peterson K.E., Hasenkrug K.J. Lactate dehydrogenase-elevating virus induces systemic lymphocyte activation via TLR7-dependent IFN-alpha responses by plasmacytoid dendritic cells. PLoS One 2009, 4:e6105.
2. Barrett B.S., Smith D.S., Li S.X., Guo K., Hasenkrug K.J., Santiago M.L. A single nucleotide polymorphism in Tetherin promotes retrovirus restriction in vivo. PLoS Pathog. 2012, 8:e1002596.
3. Castelli J.C., Hassel B.A., Maran A., Paranjape J., Hewitt J.A., Li X.L., Hsu Y.T., Silverman R.H., Youle R.J. The role of 2'-5' oligoadenylate-activated ribonuclease L in apoptosis. Cell Death Differ. 1998, 5:313-320.
4. Chakrabarti A., Jha B.K., Silverman R.H. New insights into the role of RNase L in innate immunity. J. Interferon Cytokine Res. 2011, 31:49-57.
5. Chesebro B., Wehrly K. Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex. Proc. Nat. Acad. Sci. U.S.A. 1979, 76:425-429.
6. Chesebro B., Britt W., Evans L., Wehrly K., Nishio J., Cloyd M. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus. Virology 1983, 127:134-148.
7. Dimitrova D.I., Reichenbach N.L., Yang X., Pfleiderer W., Charubala R., Gaughan J.P., Suh B., Henderson E.E., Suhadolnik R.J., Rogers T.J. Inhibition of HIV type 1 replication in CD4+ and CD14+ cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5A(N6B). AIDS Res. Hum. Retroviruses 2007, 23:123-134.
8. Dittmer U., Race B., Peterson K.E., Stromnes I.M., Messer R.J., Hasenkrug K.J. Essential roles for CD8+ T cells and gamma interferon in protection of mice against retrovirus-induced immunosuppression. J. Virol. 2002, 76:450-454.
9. Dong B., Silverman R.H. 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J. Biol. Chem. 1995, 270:4133-4137.
10. Duggal N.K., Emerman M. Evolutionary conflicts between viruses and restriction factors shape immunity. Nat. Rev. Immunol. 2012, 12:687-695.
11. Duley A.K., Ploquin M.J., Eksmond U., Ammann C.G., Messer R.J., Myers L., Hasenkrug K.J., Kassiotis G. Negative impact of IFN-γ on early host immune responses to retroviral infection. J. Immunol. 2012, 189:2521-2529.
12. Floyd-Smith G., Slattery E., Lengyel P. Interferon action: RNA cleavage pattern of a (2'-5')oligoadenylate-dependent endonuclease. Science 1981, 212:1030-1032.
13. Gerlach N., Schimmer S., Weiss S., Kalinke U., Dittmer U. Effects of type I interferons on Friend retrovirus infection. J. Virol. 2006, 80:3438-3444.
14. Halemano K., Harper M.S., Guo K., Li S.X., Heilman K.J., Barrett B.S., Santiago M.L. Humoral immunity in the Friend retrovirus infection model. Immunol. Res. 2013, 55:249-260.
15. Hasenkrug K.J., Valenzuela A., Letts V.A., Nishio J., Chesebro B., Frankel W.N. Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. J. Virol. 1995, 69:2617-2620.
16. Han J.Q., Wroblewski G., Xu Z., Silverman R.H., Barton D.J. Sensitivity of hepatitis C virus RNA to the antiviral enzyme ribonuclease L is determined by a subset of efficient cleavage sites. J. Interferon Cytokine Res. 2004, 24:664-676.
17. Harper M.S., Barrett B.S., Smith D.S., Li S.X., Gibbert K., Dittmer U., Hasenkrug K.J., Santiago M.L. IFN-alpha treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3. J. Immunol. 2013, 190:1583-1590.
18. He J.Y., Cheng H.J., Wang Y.F., Zhu Y.T., Li G.Q. Development of a real-time quantitative reverse transcriptase PCR assay for detection of the Friend leukemia virus load in murine plasma. J. Virol. Methods 2008, 147:245-350.
19. Jones P.H., Mehta H.V., Okeoma C.M. A novel role for APOBEC3: susceptibility to sexual transmission of murine acquied immunodeficiency virus (mAIDS) is aggravated in APOBEC3 deficient mice. Retrovirology 2012, 9:50.
20. Kakuta S., Shibata S., Iwakura Y. Genomic structure of the mouse 2',5'-oligoadenylate synthetase gene family. J. Interferon Cytokine Res. 2002, 22:981-993.
21. Konuma T., Nakamura S., Miyagi S., Negishi M., Chiba T., Oguro H., Yuan J., Mochizuki-Kashio M., Ichikawa H., Miyoshi H., Vidal M., Iwama A. Forced expression of the histone demethylase Fbxl10 maintains self-renewing hematopoietic stem cells. Exp. Hematol. 2011, 39:697-709.
22. Kolokithas A., Rosenke K., Malik F., Hendrick D., Swanson L., Santiago M.L., Portis J.L., Hasenkrug K.J., Evans L.H. The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3. J. Virol. 2010, 84:10933-10936.
23. Kubota K., Nakahara K., Ohtsuka T., Yoshida S., Kawaguchi J., Fujita Y., Ozeki Y., Hara A., Yoshimura C., Furukawa H., Haruyama H., Ichikawa K., Yamashita M., Matsuoka T., Iijima Y. Identification of 2'-phophodiesterase, which plays a role in the 2-5A system regulated by interferon. J. Biol. Chem. 2004, 279:37832-37841.
24. Lengyel P., Samanta H., Pichon J., Dougherty J., Slattery E., Farrell P. Double-stranded RNA and the enzymology of interferon action. Ann. N.Y. Acad. Sci. 1980, 350:441-447.
25. Liu S.Y., Sanchez D.J., Aliyari R., Lu S., Cheng G. Systematic identification of type I and type II interferon-induced antiviral factors. Proc. Nat. Acad. Sci. U.S.A. 2012, 109:4239-4244.
26. Low A., Okeoma C.M., Lovsin N., de las Heras M., Taylor T.H., Peterlin B.M., Ross S.R., Fan H. Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene. Virology 2009, 385:455-463.
27. Maitra R.K., Silverman R.H. Regulation of human immunodeficiency virus replication by 2',5'-oligoadenylate-dependent RNase L. J. Virol. 1998, 72:1146-1152.
28. Malathi K., Dong B., Gale M., Silverman R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007, 448:816-819.
29. Malathi K., Saito T., Crochet N., Barton D.J., Gale M., Silverman R.H. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA 2010, 16:2108-2119.
30. Malim M.H., Bieniasz P.D. HIV restriction factors and mechanisms of evasion. Cold Spring Harb. Perspect. Med. 2012, 2:a006940.
31. Marques R., Antunes I., Eksmond U., Stoye J., Hasenkrug K.J., Kassiotis G. Lymphocyte activation by coinfection prevents immune control of Friend virus infection. J. Immunol. 2008, 181:3432-3440.
32. Nair S., Bayer W., Ploquin M.J., Kassiotis G., Hasenkrug K.J., Dittmer U. Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model. Retrovirology 2011, 8:76.
33. Okeoma C.M., Lovsin N., Peterlin B.M., Ross S.R. APOBEC3 inhibits mouse mammary tumuor virus replication in vivo. Nature 2008, 445:927-930.
34. Player M.R., Torrence P.F. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol. Ther. 1998, 78:55-113.
35. Portis J.L., McAtee F.J., Kayman S.C. Infectivity of retroviral DNA in vivo. J. AIDS 1992, 5:1272-1273.
36. Robertson M.N., Miyazawa M., Mori S., Caughey B., Evans L.H., Hayes S.F., Chesebro B. Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting. J. Virol. Methods 1991, 34:255-271.
37. Robertson S.J., Ammann C.G., Messer R.J., Carmody A.B., Myers L., Dittmer U., Nair S., Gerlach N., Evans L.H., Cafruny W.A., Hasenkrug K.J. Suppression of acute anti-Friend virus CD8+ T cell responses by coinfection with lactate-dehydrogenase elevating virus. J. Virol. 2008, 82:408-418.
38. Samuel M.A., Whitby K., Keller B.C., Marri A., Barchet W., Williams B.R., Silverman R.H., Gale M., Diamond M.S. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 2006, 80:7009-7019.
39. Santiago M.L., Montano M., Benitez R., Messer R.J., Yonemoto W., Chesebro B., Hasenkrug K.J., Greene W.C. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 2008, 321:1343-1346.
40. Santiago M.L., Benitez R.L., Montano M., Hasenkrug K.J., Greene W.C. Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. J. Immunol. 2010, 185:1114-1123.
41. Santiago M.L., Smith D.S., Barrett B.S., Montano M., Benitez R.L., Pelanda R., Hasenkrug K.J., Greene W.C. Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor. J. Virol. 2011, 85:189-199.
42. Schoggins J.W., Wilson S.J., Panis M., Murphy M.Y., Jones C.T., Bieniasz P., Rice C.M. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011, 472:481-485.
43. Schroder H.C., Wenger R., Kuchino Y., Muller W.E. Modulation of nuclear matrix-associated 2',5'-oligoadenylate metabolism and ribonuclease L activity in H9 cells by human immunodeficiency virus. J. Biol. Chem. 1989, 264:5669-5673.
44. Silverman R.H., Skehel J.J., James T.C., Wreschner D.H., Kerr I.M. rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells. J. Virol. 1983, 46:1051-1055.
45. Smith D.S., Guo K., Barrett B.S., Heilman K.J., Evans L.H., Hasenkrug K.J., Greene W.C., Santiago M.L. Noninfectious retrovirus particles drive the Apobec3/Rfv3 dependent neutralizing antibody response. PLoS Pathog. 2011, 7:e1002284.
46. Steeves R.A., Eckner R.J., Mirand E.A., Priore R.L. Rapid assay of murine leukemia virus helper activity for Friend spleen focus-forming virus. J. Nat. Cancer Inst. 1971, 46:1219-1228.
47. Takeda E., Tsuji-Kawahara S., Sakamoto M., Langlois M.A., Neuberger M.S., Rada C., Miyazawa M. Mouse APOBEC3 restricts Friend leukemia virus infection and pathogenesis in vivo. J. Virol. 2008, 82:10998-11008.
48. Tsuji-Kawahara S., Chikaishi T., Takeda E., Kato M., Kinoshita S., Kajiwara E., Takamura S., Miyazawa M. Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in Friend virus-infected mice. J. Virol. 2010, 84:6082-6095.
49. Watts J.M., Dang K.K., Gorelick R.J., Leonard C.W., Bess J.W., Swanstrom R., Burch C.L., Weeks K.M. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 2009, 460:711-716.
50. Wreschner D.H., McCauley J.W., Skehel J.J., Kerr I.M. Interferon action-sequence specificity of the ppp(A2'p)nA-dependent ribonuclease. Nature 1981, 289:414-417.
51. Zhou A., Hassel B.A., Silverman R.H. Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 1993, 72:753-765.
52. Zhou A., Paranjape J., Brown T.L., Nie H., Naik S., Dong B., Chang A., Trapp B., Fairchild R., Colmenares C., Silverman R.H. Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L. EMBO J. 1997, 16:6355-6363.